10. Cortes R., Gueye B., Pazos A., Probst A. and Palacios J. M. (1989) Dopamine receptors in human brain:
autoradiographic distribution of D1 sites. Neuroscience 28, 263–273.
11. Dean B., Pavey G. and Opeskin K. (1997) [3H]Raclopride binding to brain tissue from subjects with schizophrenia:
methodological aspects. Neuropharmacology 36, 779–786.
12. De Keyser J. (1993) Subtypes and localization of dopamine receptors in human brain. Neurochem. Int. 22,
83–93.
13. De Keyser J., Ebinger G. and Vauquelin G. (1990) Age-related changes in the human nigrostriatal dopaminergic
system. Ann. Neurol. 27, 157–161.
14. De Keyser J., Ebinger G. and Vauquelin G. (1990) D1-dopamine receptor abnormality in frontal cortex points to a
functional alteration of cortical cell membranes in Alzheimer's disease. Archs Neurol. 47, 761–763.
15. Donnan G. A., Kaczmarczyk S. J., Paxinos G., Chilco P. J., Kalnins R. M., Woodhouse D. G. and Mendelsohn F. A.
(1991) Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H]mazindol
autoradiography. J. comp. Neurol. 304, 419–434.
16. Donnemiller E., Heilmann J., Wenning G. K., Berger W., Decristoforo C., Moncayo R., Poewe W. and Ransmayr G.
(1997) Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission
tomography in dementia of the Alzheimer-type and diVuse Lewy body disease. Eur. J. Nucl. Med. 24, 320–325.
17. Graham W. C., Clarke C. E., Boyce S., Sambrook M. A., Crossman A. R. and WoodruV G. N. (1990)
Autoradiographic studies in animal models of hemi-Parkinsonism reveal dopamine D2 but not D1 receptor
supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis). Brain Res. 514,
103–110.
18. Graham W. C., Sambrook M. A. and Crossman A. R. (1993) DiVerential eVect of chronic dopaminergic treatment on
dopamine D1 and D2 receptors in the monkey brain in MPTP-induced Parkinsonism. Brain Res. 602, 290–303.
19. Groppetti A., Algeri S., Cattabeni F., Di Giulio A. M., Galli C. L., Ponzio F. and Spano P. F. (1977) Changes in
specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons.
J. Neurochem. 28, 193–197.
20. Gurevich E. V., Bordelon Y., Shapiro R. M., Arnold S. E., Gur R. E. and Joyce J. N. (1997) Mesolimbic dopamine
D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Archs gen. Psychiat. 54,
225–232.
21. Guttman M. (1987) Receptors in the basal ganglia. Can. J. neurol. Sci. 14, 395–401.
22. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C. and Farde L. (1994) Distribution of D1- and D2-dopamine
receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11, 245–256.
23. Herroelen L., De Backer J. P., Wilczak N., Flamez A., Vauquelin G. and De Keyser J. (1994) Autoradiographic
distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin.
Brain Res. 648, 222–228.
24. Hersch S. M., Yi H., Heilman C. J., Edwards R. H. and Levey A. I. (1997) Subcellular localization and molecular
topology of the dopamine transporter in the striatum and substantia nigra. J. comp. Neurol. 388, 211–227.
25. Hietala J. and Syvalahti E. (1996) Dopamine in schizophrenia. Ann. Med. 28, 557–561.
26. Joyce J. N., Lexow N., Bird E. and Winokur A. (1988) Organization of dopamine D1 and D2 receptors in human
striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2, 546–557.
27. Kaufman M. J. and Madras B. K. (1992) Distribution of cocaine recognition sites in monkey brain: II. Ex vivo
autoradiography with [3H]CFT and [125I]RTI-55. Synapse 12, 99–111.
28. Kinnear P. R. and Grey C. D. (1994) SPSS for Windows Made Simple. Psychology Press, Hove, U.K.
29. Kish S. J., Shannak K. and Hornykiewicz O. (1988) Uneven pattern of dopamine loss in the striatum of patients with
idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New Engl. J. Med. 318, 876–880.
30. Kish S. J., Shannak K., Rajput A., Deck J. H. and Hornykiewicz O. (1992) Aging produces a specific pattern of striatal
dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58, 642–648.
31. Kohler C. and Radesater A. C. (1986) Autoradiographic visualization of dopamine D-2 receptors in the monkey brain
using the selective benzamide drug [3H]raclopride. Neurosci. Lett. 66, 85–90.
32. Kontur P. J., al-Tikriti M., Innis R. B. and Roth R. H. (1994) Postmortem stability of monoamines, their metabolites,
and receptor binding in rat brain regions. J. Neurochem. 62, 282–290.
33. Kopin I. J. (1993) The pharmacology of Parkinson's disease therapy: an update. A. Rev. Pharmac. Toxic. 32,
467–495.
34. Landwehrmeyer B., Mengod G. and Palacios J. M. (1993) Dopamine D3 receptor mRNA and binding sites in human
brain. Brain Res. molec. Brain Res. 18, 187–192.
35. Laruelle M., Abi-Dargham A., van Dyck C. H., Gil R., D'Souza C. D., Erdos J., McCance E., Rosenblatt W.,
Fingado C., Zoghbi S. S., Baldwin R. M., Seibyl J. P., Krystal J. H., Charney D. S. and Innis R. B. (1996) Single
photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. natn. Acad. Sci. U.S.A. 93, 9235–9240.
36. Levant B. (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmac. Rev. 49,
231–252.
37. Levant B. and DeSouza E. B. (1993) DiVerential pharmacological profile of striatal and cerebellar dopamine receptors
labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors. Synapse 14, 90–95.
38. Levesque D., Diaz J., Pilon C., Martres M. P., Giros B., Souil E., Schott D., Morgat J. L., Schwartz J. C. and
SokoloV P. (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using
7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. natn. Acad. Sci. U.S.A. 89, 8155–8159.
39. Levesque D., Martres M. P., Diaz J., GriVon N., Lammers C. H., SokoloV P. and Schwartz J. C. (1995) A paradoxical
regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine
neurons. Proc. natn. Acad. Sci. U.S.A. 92, 1719–1723.
40. Lewis S. W. (1996) Functional brain imaging. In Brain Imaging in Psychiatry (eds Lewis S. and Higgins N.),
pp. 108–115. Blackwell Science, Oxford.
41. Madras B. K. and Kaufman M. J. (1994) Cocaine accumulates in dopamine-rich regions of primate brain after i.v.
administration: comparison with mazindol distribution. Synapse 18, 261–275.
